Cargando…

Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy

Significant recent advances have occurred in the use of radiation therapy for locally advanced non-small cell lung cancer (LA-NSCLC). In fact, the past few decades have seen both therapeutic gains and setbacks in the evolution of radiotherapy for LA-NSCLC. The PACIFIC trial has heralded a new era of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tiantian, Zou, Liqing, Ni, Jianjiao, Chu, Xiao, Zhu, Zhengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653144/ https://www.ncbi.nlm.nih.gov/pubmed/33209629 http://dx.doi.org/10.21037/tlcr-20-511

Ejemplares similares

A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy
por: Li, Shuyan, et al.
Publicado: (2020)

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
por: Zhou, Yue, et al.
Publicado: (2020)

Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer
por: Jiang, Shanshan, et al.
Publicado: (2022)

Is clinical target volume necessary?—a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique
por: Zou, Liqing, et al.
Publicado: (2020)

Identification of lncRNA, MicroRNA, and mRNA-Associated CeRNA Network of Radiation-Induced Lung Injury in a Mice Model
por: Li, Yida, et al.
Publicado: (2019)

LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a
por: Yang, Xi, et al.
Publicado: (2020)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
por: Zhang, Xiaofei, et al.
Publicado: (2018)

Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database
por: Zou, Liqing, et al.
Publicado: (2020)

Identification and Integrated Analysis of circRNA and miRNA of Radiation-Induced Lung Injury in a Mouse Model
por: Li, Yida, et al.
Publicado: (2021)

Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury
por: Guo, Tiantian, et al.
Publicado: (2020)

Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses
por: Ni, Jianjiao, et al.
Publicado: (2019)

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
por: Middleton, Mark R., et al.
Publicado: (2020)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status
por: Zhang, Jinmeng, et al.
Publicado: (2022)

Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs
por: Zeng, Ya, et al.
Publicado: (2023)

Immunotherapies for pediatric cancer: current landscape and future perspectives
por: Hutzen, Brian, et al.
Publicado: (2019)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease
por: Zeng, Ya, et al.
Publicado: (2020)

A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
por: Prasad, Rahul N., et al.
Publicado: (2020)

Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives
por: Soares do Brito, Joaquim, et al.
Publicado: (2022)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Current landscape and future directions of bispecific antibodies in cancer immunotherapy
por: Wei, Jing, et al.
Publicado: (2022)

Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Chu, Xiao, et al.
Publicado: (2019)

STING signaling activation modulates macrophage polarization via CCL2 in radiation-induced lung injury
por: Ni, Jianjiao, et al.
Publicado: (2023)

Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations
por: Ward, Tim H, et al.
Publicado: (2021)

The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study
por: Zheng, Zhiqin, et al.
Publicado: (2023)

Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?
por: Chu, Li, et al.
Publicado: (2022)

Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters
por: Zeng, Ya, et al.
Publicado: (2022)

Radiotherapy: Brightness and darkness in the era of immunotherapy
por: Zhai, Danyi, et al.
Publicado: (2022)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

Lattice or Oxygen-Guided Radiotherapy: What If They Converge? Possible Future Directions in the Era of Immunotherapy
por: Ferini, Gianluca, et al.
Publicado: (2021)

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
por: Wang, Yifan, et al.
Publicado: (2018)

Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial
por: Ni, Jianjiao, et al.
Publicado: (2021)

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
por: Lim, Sun Min, et al.
Publicado: (2020)

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
por: Modi, Dipenkumar, et al.
Publicado: (2021)

Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives
por: Valenza, Carmine, et al.
Publicado: (2023)

Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
por: Imai, Reiko, et al.
Publicado: (2018)

Results of photon radiotherapy for unresectable salivary gland tumors: is neutron radiotherapy’s local control superior?
por: Spratt, Daniel E., et al.
Publicado: (2014)

A “Seed-and-Soil” Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation
por: Chu, Xiao, et al.
Publicado: (2023)

Immunotherapy as sensitizer for local radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rskjaojt68fccrpuiuvrik0bo0